Kizilay T, Akbayir E, Erol R, Demir AS, et al. Altered cerebrospinal fluid neurofilament light chain but not neurogranin levels are associated with response to ocrelizumab treatment in relapsing remitting multiple sclerosis: a preliminary study. Eur Neurol 2024 May 16. doi: 10.1159/000539376.
PMID: 38754397